Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.

Ruiz-Arruza I, Barbosa C, Ugarte A, Ruiz-Irastorza G.

Autoimmun Rev. 2015 Jun 1. pii: S1568-9972(15)00119-6. doi: 10.1016/j.autrev.2015.05.011. [Epub ahead of print] Review.

PMID:
26044819
2.

Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients.

Les I, Pijoán JI, Rodríguez-Álvarez R, Ruiz-Irastorza G, Martínez-Berriotxoa A.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-90-7. Epub 2015 May 26.

PMID:
26016756
3.

Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

Arthritis Rheumatol. 2015 Jul;67(7):1837-47. doi: 10.1002/art.39111.

PMID:
25778456
4.

State of the art: Reproduction and pregnancy in rheumatic diseases.

Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse ME, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M.

Autoimmun Rev. 2015 May;14(5):376-86. doi: 10.1016/j.autrev.2014.12.011. Epub 2014 Dec 30. Review.

PMID:
25555818
5.

Prevalence and significance of persistently positive antiphospholipid antibodies in women with preeclampsia.

Gonzalez-Echavarri C, Villar I, Ugarte A, Larrieta R, Ruiz-Irastorza G.

J Rheumatol. 2015 Feb;42(2):210-3. doi: 10.3899/jrheum.140737. Epub 2014 Dec 15.

PMID:
25512484
6.

[Metabolic syndrome in patients with systemic lupus erythematosus: causes and consequences].

Erdozain JG, Ruiz Irastorza G.

Med Clin (Barc). 2015 Apr 8;144(7):309-11. doi: 10.1016/j.medcli.2014.09.011. Epub 2014 Nov 27. Spanish. No abstract available.

PMID:
25434856
7.

Dr. Erdozain, et al reply.

Erdozain JG, Villar I, Nieto J, Ruiz-Irastorza G.

J Rheumatol. 2014 Oct;41(10):2086. doi: 10.3899/jrheum.140442. No abstract available.

PMID:
25275096
8.

[Rituximab in antiphospholipid syndrome: always, never, sometimes?].

Ugarte A, Ruiz Irastorza G.

Med Clin (Barc). 2015 Feb 2;144(3):115-7. doi: 10.1016/j.medcli.2014.04.014. Epub 2014 Aug 20. Spanish. No abstract available.

PMID:
25148947
9.

Anti-C1q antibodies in systemic lupus erythematosus.

Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, Aranow CB, Manzi S, Urowitz MB, Gladman DD, Kalunian KC, Costner MI, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, Van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS, Petri M.

Lupus. 2015 Jan;24(1):42-9. doi: 10.1177/0961203314547791. Epub 2014 Aug 14.

PMID:
25124676
10.

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Petri M, Steinsson K, Dooley MA, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Urowitz MB.

Ann Rheum Dis. 2014 May 16. pii: annrheumdis-2013-205171. doi: 10.1136/annrheumdis-2013-205171. [Epub ahead of print]

11.

Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.

Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Hanly JG, Petri M, Steinsson K, Dooley MA, Manzi S, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim SS, Kamen DL, Peschken CA, Inanc M, Bruce IN.

Ann Rheum Dis. 2015 Aug;74(8):1530-6. doi: 10.1136/annrheumdis-2013-203933. Epub 2014 Apr 1.

12.

Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.

Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G.

Rheumatology (Oxford). 2014 Aug;53(8):1470-6. doi: 10.1093/rheumatology/keu148. Epub 2014 Mar 27.

PMID:
24681836
13.

Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.

Gonzalez-Echavarri C, Pernas B, Ugarte A, Ruiz-Irastorza G.

Lupus. 2014 Mar;23(3):323-6. doi: 10.1177/0961203314520842.

PMID:
24531426
14.

Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors.

Erdozain JG, Villar I, Nieto J, Ruiz-Irastorza G.

J Rheumatol. 2014 Feb;41(2):310-7. doi: 10.3899/jrheum.130817. Epub 2014 Jan 15.

PMID:
24429176
15.

Prednisone in lupus nephritis: how much is enough?

Ruiz-Irastorza G, Danza A, Perales I, Villar I, Garcia M, Delgado S, Khamashta M.

Autoimmun Rev. 2014 Feb;13(2):206-14. doi: 10.1016/j.autrev.2013.10.013. Epub 2013 Nov 2.

PMID:
24189280
16.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, Fortin PR, Gladman DD, Fessler BJ, Alarcón GS, Bruce IN, Dooley MA, Steinsson K, Khamashta MA, Ramsey-Goldman R, Manzi S, Sturfelt GK, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Aranow C, Mackay M, Ruiz-Irastorza G, Kalunian KC, Lim SS, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Theriault C, Thompson K, Farewell V.

Arthritis Rheum. 2013 Nov;65(11):2887-97. doi: 10.1002/art.38106. Erratum in: Arthritis Rheum. 2014 Jun;66(6):1671.

17.

Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.

Danza A, Ruiz-Irastorza G.

Lupus. 2013 Oct;22(12):1286-94. doi: 10.1177/0961203313493032. Review.

PMID:
24098001
18.

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).

Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A, Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA.

Rheumatology (Oxford). 2014 Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4.

PMID:
24097288
19.

Breast cancer in systemic lupus erythematosus.

Tessier Cloutier B, Clarke AE, Ramsey-Goldman R, Wang Y, Foulkes W, Gordon C, Hansen JE, Yelin E, Urowitz MB, Gladman D, Fortin PR, Wallace DJ, Petri M, Manzi S, Ginzler EM, Labrecque J, Edworthy S, Dooley MA, Senécal JL, Peschken CA, Bae SC, Isenberg D, Rahman A, Ruiz-Irastorza G, Hanly JG, Jacobsen S, Nived O, Witte T, Criswell LA, Barr SG, Dreyer L, Sturfelt G, Bernatsky S.

Oncology. 2013;85(2):117-21. doi: 10.1159/000353138. Epub 2013 Jul 25.

20.

Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.

Ochoa E, Iriondo M, Bielsa A, Ruiz-Irastorza G, Estonba A, Zubiaga AM.

PLoS One. 2013 Jul 3;8(7):e67897. doi: 10.1371/journal.pone.0067897. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk